Brickwood Asset Management LLP Purchases New Stake in DENTSPLY SIRONA Inc. $XRAY

Brickwood Asset Management LLP purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the second quarter, HoldingsChannel reports. The firm purchased 27,139 shares of the medical instruments supplier’s stock, valued at approximately $431,000. DENTSPLY SIRONA comprises 0.3% of Brickwood Asset Management LLP’s investment portfolio, making the stock its 6th largest position.

Other large investors have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in DENTSPLY SIRONA in the 1st quarter valued at $25,000. Brooklyn Investment Group bought a new stake in DENTSPLY SIRONA in the 1st quarter valued at $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA in the 1st quarter valued at $26,000. Trust Co. of Toledo NA OH bought a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $27,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in DENTSPLY SIRONA by 8,003.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 2,241 shares during the period. Institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

XRAY has been the topic of a number of research reports. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. UBS Group decreased their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Finally, Barrington Research decreased their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $18.00.

Read Our Latest Analysis on XRAY

DENTSPLY SIRONA Stock Performance

XRAY opened at $13.11 on Monday. The firm has a market cap of $2.62 billion, a P/E ratio of -2.77, a price-to-earnings-growth ratio of 0.82 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 52-week low of $11.69 and a 52-week high of $24.86. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The business’s fifty day moving average is $13.35 and its 200-day moving average is $14.52.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date of this dividend was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio is -13.50%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.